• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency.

作者信息

Callen J P, Hodge S J, Kulick K B, Stelzer G, Buchino J J

出版信息

Arch Dermatol. 1987 Jan;123(1):66-70.

PMID:3467658
Abstract

Deficiency of the second component of complement (C2d) has been associated with systemic lupus erythematosus (LE)-like syndromes as well as recurrent infections. In particular, C2d has been associated with the LE subset of subacute cutaneous LE (SCLE), the presence of anti-Ro antibodies (anti-Ro or SS-A), and the human leukocyte antigen (HLA) types A25, B18, and DR2. A family with C2d in which three members have developed SCLE was observed and studied clinically, serologically, and immunogenetically. Deficiency of the second component of complement was present in all six family members, while anti-Ro was present in only two. There was a strong but incomplete association of C2d and SCLE with HLA-DR2, but the association was not complete with positivity of anti-Ro or antinuclear antibodies. Study of this family reconfirmed the close association of HLA-A25, -B18 and -DR2 with the C2 gene, but indicated a less close association of these loci with serologic markers.

摘要

相似文献

1
Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency.
Arch Dermatol. 1987 Jan;123(1):66-70.
2
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.对于一名存在C2缺陷的患者,氨苯砜是治疗亚急性皮肤型红斑狼疮和荨麻疹性血管炎皮肤损害的有效疗法。
J Rheumatol. 1990 Sep;17(9):1222-5.
3
Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.抗Ro(SS-A) HLA-DR3阳性女性:一些ANA阴性、干燥综合征(SS)、亚急性皮肤型红斑狼疮(SCLE)和新生儿红斑狼疮(NLE)母亲与SS/LE重叠女性患者之间的相互关系。
J Invest Dermatol. 1993 Jan;100(1):14S-20S. doi: 10.1111/1523-1747.ep12355186.
4
Serologic studies in a family with heterozygous C2 deficiency.对一个患有杂合子C2缺乏症的家族进行的血清学研究。
Am J Med. 1981 Dec;71(6):945-8. doi: 10.1016/0002-9343(81)90311-9.
5
Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus.皮肤红斑狼疮免疫遗传特征及光敏性的种族差异。
Arch Dermatol Res. 2009 Jan;301(1):111-5. doi: 10.1007/s00403-008-0897-3. Epub 2008 Sep 17.
6
C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies.C2缺陷型系统性红斑狼疮:其与抗Ro(SSA)抗体的关联。
Arch Dermatol. 1982 Aug;118(8):584-7.
7
Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.Ro(SS-A)阳性的干燥综合征/红斑狼疮(SC/LE)重叠综合征患者与HLA-DR3和/或DRw6表型相关。
J Invest Dermatol. 1988 Oct;91(4):369-71. doi: 10.1111/1523-1747.ep12476204.
8
Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.系统性红斑狼疮:临床表现与抗Ro/SS——有和无亚急性皮肤型红斑狼疮皮损患者的反应
Lupus. 1997;6(1):32-9. doi: 10.1177/096120339700600105.
9
Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.C4、C2或C1q基因缺陷与狼疮综合征。与抗Ro(SS-A)抗体的关联。
Clin Exp Immunol. 1985 Dec;62(3):678-84.
10
HLA and genetic predisposition to lupus erythematosus and other dermatologic disorders.人类白细胞抗原与红斑狼疮及其他皮肤病的遗传易感性
J Am Acad Dermatol. 1985 Sep;13(3):472-81. doi: 10.1016/s0190-9622(85)70191-0.

引用本文的文献

1
The Genetic Landscape of Cutaneous Lupus Erythematosus.皮肤红斑狼疮的遗传图谱
Front Med (Lausanne). 2022 Jun 2;9:916011. doi: 10.3389/fmed.2022.916011. eCollection 2022.
2
Infectious diseases associated with complement deficiencies.与补体缺陷相关的传染病。
Clin Microbiol Rev. 1991 Jul;4(3):359-95. doi: 10.1128/CMR.4.3.359.